Gefitinib N-oxide

Modify Date: 2024-02-13 18:29:00

Gefitinib N-oxide Structure
Gefitinib N-oxide structure
Common Name Gefitinib N-oxide
CAS Number 847949-51-3 Molecular Weight 462.90200
Density N/A Boiling Point N/A
Molecular Formula C22H24ClFN4O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Gefitinib N-oxide


Gefitinib N-oxide is the N-oxide derivative of Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells[1][2].

 Names

Name N-(3-chloro-4-fluorophenyl)-[7-methoxy-6-(3-(4-(1-oxymorpholinyl))propoxy)-4-quinazolin]amine
Synonym More Synonyms

 Gefitinib N-oxide Biological Activity

Description Gefitinib N-oxide is the N-oxide derivative of Gefitinib. Gefitinib is an EGFR tyrosine kinase inhibitor, with IC50 of 2-37 nM in NR6wtEGFR cells[1][2].
Related Catalog
Target

IC50: 37 nM (Tyr1173 site, in NR6wtEGFR cells), 37 nM (Tyr992 site, in NR6wtEGFR cells)[1]

References

[1]. Pedersen MW, et al. Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII. Br J Cancer. 2005 Oct 17;93(8):915-23.

[2]. Moasser MM, et al. The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells. Cancer Res. 2001 Oct 1;61(19):7184-8.

 Chemical & Physical Properties

Molecular Formula C22H24ClFN4O4
Molecular Weight 462.90200
Exact Mass 462.14700
PSA 94.93000
LogP 4.32000

 Synonyms

Gefitinib Morpholine N-oxide
Gefitinib N-Oxide
gefitinib N-oxide
Gefitinib Impurity 13